Page last updated: 2024-09-04

moxifloxacin and rhodamine b

moxifloxacin has been researched along with rhodamine b in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (rhodamine b)	Trials (rhodamine b)	Recent Studies (post-2010) (rhodamine b)
3,157	552	1,690	1,758	15	1,198

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gelperina, S; Heifets, L; Higgins, MP; Kisich, KO; Oganesyan, E; Shipulo, E; Wilson, S	1

Other Studies

1 other study(ies) available for moxifloxacin and rhodamine b

Article	Year
Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. International journal of pharmaceutics, 2007, Dec-10, Volume: 345, Issue:1-2 Topics: Antitubercular Agents; Aza Compounds; Bacillus subtilis; Biological Assay; Cells, Cultured; Drug Compounding; Enbucrilate; Fluoroquinolones; Humans; Macrophages; Moxifloxacin; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Quinolines; Rhodamines; Suspensions	2007

Article

Year

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.

International journal of pharmaceutics, 2007, Dec-10, Volume: 345, Issue:1-2

Topics: Antitubercular Agents; Aza Compounds; Bacillus subtilis; Biological Assay; Cells, Cultured; Drug Compounding; Enbucrilate; Fluoroquinolones; Humans; Macrophages; Moxifloxacin; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Quinolines; Rhodamines; Suspensions

2007